Trials / Recruiting
RecruitingNCT03925701
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.
Detailed description
Clinical study evaluating vildagliptin versus vildagliptin/metformin on nonalcoholic fatty liver disease with DM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vildagliptin | vildagliptin twice daily |
| DRUG | vildagliptin\metformin | vildagliptin\\metformin twice daily |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2019-04-24
- Last updated
- 2019-04-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03925701. Inclusion in this directory is not an endorsement.